What This Immunome Sale Signals Ahead of FDA Milestone
When a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
A straightforward framework to help newcomers pick their initial cryptocurrency with confidence.
25,127 articlesWhen a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
Midyear 2026 brings a wide range of state local sales rates across the U.S. Learn how these taxes are set, who they a...
A fresh institutional stake has emerged in Victoria’s Secret stock this quarter. The $8.5 million bet suggests some m...
OpenAI wins a Pentagon deal to deploy its AI in classified systems as Anthropic is designated a supply chain risk by ...
GSK has seen a steep run in its stock, prompting questions about whether the rally still offers upside. This article ...
Bank of America projects a future where humanoid robots outnumber cars by 2060, with two-thirds living in households....
A high-profile legal clash over concert logistics shines a light on how money moves in the music business. This artic...
When a board member sells shares, investors watch closely. This article unpacks a recent Arteris insider move, what i...
Many investors chase high rents and quick profits, but smart borrowers know cash flow isn’t everything. This guide re...
Private markets are tightening their grip on everyday investing. This article explains how the line between public an...
Over the last year, ISCV outpaced IJJ, but market cycles can change on a dime. This guide explains why that edge may ...
Oklo has been the source of big talk in the stock market. This guide breaks down whether it’s truly a ticket to wealt...